Objective: To optimally leverage the scalability and unique features of the electronic health records (EHR) for research that would ultimately improve patient care, we need to accurately identify patients and extract clinically meaningful measures. Using multiple sclerosis (MS) as a proof of principle, we showcased how to leverage routinely collected EHR data to identify patients with a complex neurological disorder and derive an important surrogate measure of disease severity heretofore only available in research settings. Methods: In a cross-sectional observational study, 5,495 MS patients were identified from the EHR systems of two major referral hospitals using an algorithm that includes codified and narrative information extracted usin...
Multiple Sclerosis (MS) is the second cause of paraplegia among young adults, after all types of CNS...
<p>Overall approach for developing EHR algorithm to classify multiple sclerosis (A), and to derive s...
Abstract Objective No relapse risk prediction tool is currently available to guide treatment selecti...
ObjectiveTo optimally leverage the scalability and unique features of the electronic health records ...
Background Diagnostic accuracy might be improved by algorithms that searched patients’ clinical note...
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the ...
a<p>Observed MSSS is based on actual data from MS patients who receive care at the Partners MS Cente...
Technological innovation is transforming traditional clinical practice, enabling people with multipl...
Objectives: Patients with multiple sclerosis (MS) may have low health-related quality of life, incre...
Background: There is no consensus method for determining progression of disability in patients with ...
Background: There is no consensus method for determining progression of disability in patients with ...
ObjectiveEarly identification of chronic diseases is a pillar of precision medicine as it can lead t...
BACKGROUND: There is no consensus method for determining progression of disability in patients with ...
International audienceObjective: Multiple sclerosis (MS) is a multifactorial disease with increasing...
The Expanded Disability Status Scale (EDSS) is the current ‘gold standard’ for monitoring disease se...
Multiple Sclerosis (MS) is the second cause of paraplegia among young adults, after all types of CNS...
<p>Overall approach for developing EHR algorithm to classify multiple sclerosis (A), and to derive s...
Abstract Objective No relapse risk prediction tool is currently available to guide treatment selecti...
ObjectiveTo optimally leverage the scalability and unique features of the electronic health records ...
Background Diagnostic accuracy might be improved by algorithms that searched patients’ clinical note...
Background: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the ...
a<p>Observed MSSS is based on actual data from MS patients who receive care at the Partners MS Cente...
Technological innovation is transforming traditional clinical practice, enabling people with multipl...
Objectives: Patients with multiple sclerosis (MS) may have low health-related quality of life, incre...
Background: There is no consensus method for determining progression of disability in patients with ...
Background: There is no consensus method for determining progression of disability in patients with ...
ObjectiveEarly identification of chronic diseases is a pillar of precision medicine as it can lead t...
BACKGROUND: There is no consensus method for determining progression of disability in patients with ...
International audienceObjective: Multiple sclerosis (MS) is a multifactorial disease with increasing...
The Expanded Disability Status Scale (EDSS) is the current ‘gold standard’ for monitoring disease se...
Multiple Sclerosis (MS) is the second cause of paraplegia among young adults, after all types of CNS...
<p>Overall approach for developing EHR algorithm to classify multiple sclerosis (A), and to derive s...
Abstract Objective No relapse risk prediction tool is currently available to guide treatment selecti...